Use access key #2 to skip to page content.

FoxForce5contest (34.71)

TheFoxForceJournal

Recs

8

July 11, 2013 – Comments (11) | RELATED TICKERS: PDLI


Get Profile for: PDL BioPharma, Inc.
932 Southwood Boulevard
Incline Village, NV 89451
United States - Map
Website: http://www.pdl.com

Details Index Membership:N/ASector:HealthcareIndustry:BiotechnologyFull Time Employees:10
Business Summary 

PDL BioPharma, Inc. engages in intellectual property asset management and patent portfolio and related assets investment activities. The company is involved in the humanization of monoclonal antibodies and the discovery of a new generation of targeted treatments for cancer and immunologic diseases, as well as other medical conditions. It offers Queen et al. patents that cover humanized antibodies, methods for humanizing antibodies, polynucleotide encoding in humanized antibodies, and methods of producing humanized antibodies. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.

Key Statistics


Company Websites Home Page

Ok, I really suck at picking biotechs, so hopefully all of us foxes can figure it out in the comments section.

STAY FOXY MY FRIENDS>>>

11 Comments – Post Your Own

#1) On July 12, 2013 at 12:21 AM, HarryCarysGhost (99.71) wrote:

http://youtu.be/N3TJu9IaBAE

Report this comment
#2) On July 12, 2013 at 1:06 AM, awallejr (83.74) wrote:

I actually made irl money on one (IPXL). Gambled and got lucky.  But Porte and ZZ are apparently good at it.  Just give me 1 more year on SDRL;p

As for my IPXL pick it is an interesting story if anyone cares.  For some dumb reason I decided to sell puts on a biotech company.  I forget what drew my attention except they apparently have a serious Parkinsons medicine called Rytary in the works.  So I gambled they would get FDA approval and sure enough they got a cure letter instead lol.

The stock kept tanking and I kept writing puts for the July 20s, then the Sept 15s and 17.50s. I was bleeding red and smacking myself for getting involved in something I really didn't understand.

The stock tanked from 21 to under 15.  And then all the PR notices by the bloodsucking lawyers wanting start a class action occurred.  Man I was pissed at myself.  But slowly the stock started climbing back. 

Then come the June expiration date and the stock kept flirting under 18.  I had the 20s for $2.  I refused to lose so I said screw it I know you guys are playing games so put me the 2k shares.  Over the weekend I got them then come Monday lo and behold the CEO was retiring (a good thing) and the stock was selling near $20.  I took my money and ran and am still sitting on 15s and 17.50s which I expect to expire worthless.

Lesson learned.  The MMs DO PLAY GAMES on option expiration dates. BEWARE.

Report this comment
#3) On July 12, 2013 at 1:15 AM, portefeuille (99.66) wrote:

Ok, I really suck at picking biotechs, so hopefully all of us foxes can figure it out in the comments section.

--------

But Porte and ZZ are apparently good at it.

--------

maybe ;)

 

see this post.

biotech

Report this comment
#4) On July 12, 2013 at 2:09 AM, awallejr (83.74) wrote:

No offense Porte but ZZ did make me more CAPS points than you heheh.

Report this comment
#5) On July 12, 2013 at 2:11 AM, awallejr (83.74) wrote:

ASTX vs NAVB ;p

Report this comment
#6) On July 12, 2013 at 9:12 PM, HarryCarysGhost (99.71) wrote:

Hey Andy, funny you should mention the M&M's and their HFT's.

Looking at the volume (3M avg- 1,876,330)

and short ratio of PDLI (13.10%)

I would suspect that this one is being manipulated for sure.

My question is that since this is one of the rare small cap biotech that pays a dividend (it's really more of a royalty trust like SLW). Is there a massive short cover before EX-date? And is that a possible investable trend.

Not that I would do it, too risky for my tastes, but still interesting.

Thanks Porte, I missed that blog. I'll have to check twitter more often.

 

Report this comment
#7) On July 12, 2013 at 9:57 PM, HarryCarysGhost (99.71) wrote:

If Momentum21 had rolled large (like Scruffy would)

The 40,000 shares bought on 8-8-12 @ $7.38 for $295,200, would have collected  $24,000 in dividends paid in just 4 QTRS.

Sitting pretty with $351,200, and the decision whether to hold or take the money and run as some patents may be running out.

Not too shabby.

 

 

Report this comment
#8) On July 12, 2013 at 11:44 PM, awallejr (83.74) wrote:

Well I do know there are many strategies on Ex-div dates which are perfectly legitimate.  But option expirations, I dunno, sometimes the manipulation seems so obvious.

As Napoleon once said, don't let events control you, you must control the events.  Of course he did blow it at Waterloo heheh.

Report this comment
#9) On July 17, 2013 at 3:58 PM, awallejr (83.74) wrote:

Forbes likes my IPXL put strategy, although I was ahead of them when the stock was selling for $15 and collected much sweeter premiums.

 http://us.rd.yahoo.com/finance/external/forbes/SIG=13srifa0m/*http://www.forbes.com/sites/stockoptionschannel/2013/07/17/commit-to-buy-impax-laboratories-at-17-50-earn-10-6-annualized/?partner=yahootix

Report this comment
#10) On July 17, 2013 at 7:48 PM, HarryCarysGhost (99.71) wrote:

Nice Man!

Just something I wouldn't be comfortable with (don't wan't to be told when to sell) but your trade looks pretty safe (and profitable)

I'll stick with my DCA and Drip'n, once you get that dividend train moving, it starts to go really, really fast.

Cheers.

 

 

Report this comment
#11) On August 04, 2013 at 6:38 PM, Momentum21 (92.04) wrote:

Hey all, I didn't roll large on PDLI and basically chose it in the contest on speculation that it would track ahead of the IBB in an up market. And it is also a rare biotech paying a dividend on some quickly expiring royalty deals.  

Unfortunately I did invest in a basket of small cap biotechs and only own IBB for my wife's 401k...therefore I am banished to the land of underperformance in my discretionary fund over the past 3 years or so.

Porte has managed to outpace that index which is extremely impressive to say the least. 

I wouldn't be short PDLI but investing in their game seems riskier than the average smallcap bio with much less upside potential. At some point they are going to go to the well and throw some additional shares into the market to guarantee the executive team everything they ever wanted in the lovely vacation destination of Incline Village, NV.,,a town that I do love to visit often.  

Report this comment

Featured Broker Partners


Advertisement